Gianluigi Zaza Selected Research

Medullary Sponge Kidney

6/2022	A Comprehensive Proteomics Analysis of Urinary Extracellular Vesicles Identifies a Specific Kinase Protein Profile as a Novel Hallmark of Medullary Sponge Kidney Disease.
1/2021	Sphingomyelin and Medullary Sponge Kidney Disease: A Biological Link Identified by Omics Approach.
11/2019	Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease.
1/2019	Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.
8/2017	New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers.
1/2017	Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluigi Zaza Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 02/2014
15	Chronic Renal Insufficiency 01/2022 - 05/2008
12	Fibrosis (Cirrhosis) 12/2020 - 01/2008
8	Inflammation (Inflammations) 12/2020 - 06/2015
6	Medullary Sponge Kidney 06/2022 - 01/2017
6	COVID-19 01/2021 - 01/2020
6	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 05/2017
5	Delayed Graft Function 04/2022 - 03/2011
5	Reperfusion Injury 04/2022 - 03/2011
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 08/2010
4	Ischemia 04/2022 - 01/2016
4	Nephrolithiasis 01/2021 - 01/2017
4	Infections 11/2020 - 02/2014
4	Kidney Diseases (Kidney Disease) 10/2020 - 01/2017
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 10/2012
4	Proteinuria 01/2020 - 12/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 10/2021 - 03/2013
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2021 - 12/2019
3	Hypoxia (Hypoxemia) 01/2018 - 08/2015
3	Glomerulonephritis 03/2016 - 02/2013
3	Drug-Related Side Effects and Adverse Reactions 02/2015 - 07/2014
3	Renal Insufficiency (Renal Failure) 02/2015 - 10/2012
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2005 - 09/2004
2	Carcinogenesis 01/2022 - 01/2020
2	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021 - 01/2021
2	Hematuria 01/2020 - 09/2012
2	Albuminuria 01/2019 - 11/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2018 - 12/2016
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Sclerosis 10/2021
1	Peritoneal Fibrosis 10/2021
1	Cytokine Release Syndrome 01/2021
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2020
1	Segmental glomerulosclerosis 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Atypical Hemolytic Uremic Syndrome 12/2019
1	Thyroid Nodule (Nodule, Thyroid) 12/2019
1	Papillary Thyroid Cancer 12/2019
1	Hemorrhage 12/2019
1	Lymphoma (Lymphomas) 09/2019
1	T-Cell Leukemia (Leukemia, T Cell) 09/2019

Drug/Important Bio-Agent (IBA)

12	Biological ProductsIBA 01/2022 - 03/2014
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
9	heparanaseIBA 01/2020 - 09/2014
6	CalciumIBA 01/2021 - 03/2009
4	TOR Serine-Threonine KinasesIBA 01/2022 - 08/2015
4	Complement System Proteins (Complement)IBA 01/2020 - 02/2014
4	Glycoside Hydrolases (Endoglycosidases)IBA 11/2018 - 10/2012
4	Everolimus FDA Link 04/2018 - 08/2015
3	SteroidsIBA 10/2021 - 02/2014
3	CytokinesIBA 11/2020 - 01/2015
3	CreatinineIBA 01/2020 - 11/2018
3	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 08/2015 - 10/2012
3	Therapeutic UsesIBA 02/2015 - 07/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2015
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2008
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 08/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2016
2	Immunoglobulin G (IgG)IBA 11/2020 - 01/2019
2	AntibodiesIBA 11/2020 - 01/2019
2	Immunoglobulin M (IgM)IBA 11/2020 - 01/2019
2	Immunoglobulin A (IgA)IBA 01/2020 - 02/2013
2	C-Reactive ProteinIBA 11/2018 - 03/2009
2	SST 0001IBA 01/2018 - 01/2016
2	Heparitin Sulfate (Heparan Sulfate)IBA 05/2017 - 10/2012
2	Fibronectins (Fibronectin)IBA 05/2017 - 08/2015
2	VimentinIBA 05/2017 - 08/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 08/2009
2	Calcineurin InhibitorsIBA 10/2014 - 12/2010
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 09/2005 - 09/2004
2	Methotrexate (Mexate)FDA LinkGeneric 01/2005 - 09/2004
1	Protein Kinases (Protein Kinase)IBA 06/2022
1	AntioxidantsIBA 04/2022
1	MTOR InhibitorsIBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	GlucocorticoidsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	mesoglycanIBA 01/2021
1	SphingomyelinsIBA 01/2021
1	ElementsIBA 12/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	ParaffinIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020

Therapy/Procedure

13	Kidney Transplantation 04/2022 - 03/2011
10	Transplantation 04/2022 - 03/2015
6	Renal Dialysis (Hemodialysis) 01/2021 - 03/2009
5	Peritoneal Dialysis 10/2021 - 05/2008
4	Therapeutics 06/2020 - 02/2014
1	Organ Transplantation 01/2022
1	Thyroidectomy 12/2019